P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,451.50
109.85 (2.06%)
BSENSE

May 21

BSE+NSE Vol: 20.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
227.37
436.29
191.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
227.37
436.29
191.89%
Raw Material Cost
137.67
83.76
53.91
64.36%
Purchase of Finished goods
34.95
9.30
25.65
275.81%
(Increase) / Decrease In Stocks
-10.23
-19.47
9.24
47.46%
Employee Cost
109.89
56.16
53.73
95.67%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
41.49
139.28
335.70%
Total Expenditure (Excl Depreciation)
453.05
171.23
281.82
164.59%
Operating Profit (PBDIT) excl Other Income
210.61
56.14
154.47
275.15%
Other Income
8.98
34.73
-25.75
-74.14%
Operating Profit (PBDIT)
219.59
90.87
128.72
141.65%
Interest
0.24
4.68
-4.44
-94.87%
Exceptional Items
0.00
-6.75
6.75
100.00%
Gross Profit (PBDT)
219.35
79.44
139.91
176.12%
Depreciation
11.52
25.74
-14.22
-55.24%
Profit Before Tax
207.83
53.71
154.12
286.95%
Tax
53.11
2.18
50.93
2,336.24%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
51.53
103.19
200.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
51.53
103.19
200.25%
Equity Capital
16.60
9.78
6.82
69.73%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
2.63
90.57
3,443.73%
Diluted Earnings per share
93.21
2.63
90.58
3,444.11%
Operating Profit Margin (Excl OI)
31.73%
24.69%
0.00
7.04%
Gross Profit Margin
33.05%
34.94%
0.00
-1.89%
PAT Margin
23.31%
22.66%
0.00
0.65%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024